$AEO

American Eagle (AEO) Q2 2026 Earnings Call Transcript

American Eagle (AEO) reported Q2 2026 revenue of $1.38B, up 8%, driven by Aerie's 25% growth. Operating profit was $211M, including $161M in tariff refunds. Aerie's revenue hit $536M, while American Eagle saw a 1% revenue increase. EPS rose to $0.79. Management guided Q3 comparable sales growth to mid- to high single digits and operating income to $110M-$115M.

Original reporting
Published Sep 10, 2026, 4:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 10, 2026, 5:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
American Eagle (AEO) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$AEOBullishHigh
01

Why it matters

Earnings beat expectations with strong Aerie growth, but elevated SG&A and inventory costs may limit near‑term upside.

02

Market read

First earnings disclosure provides fresh data and guidance, offering actionable insight for traders.

03

What to watch

Tariff refund benefit may be non-recurring; future freight cost exposure noted.

Relevance 8/10Novelty 8/10Timing: post-earnings Q2 2026 release

Background

American Eagle Outfitters (NYSE:AEO) reported Q2 2026 results, highlighting Aerie's performance and tariff refund impact.

Company-level read

Ticker impact

$AEOBullishHigh confidence
Context

Q2 2026 earnings release with revenue, EPS, margin and guidance numbers.

Expected impact

Potential upside as investors price in higher earnings and guidance.

Evidence & confidence

First report of earnings and guidance; material financial metrics and forward outlook.

Market effects

Aerie's growth may boost the broader apparel and specialty retail sector.

U.S. consumer discretionary market could see modest lift.

Limited to U.S. retail; no direct global macro effect.

Counterpoint

Higher SG&A and inventory costs could pressure margins if demand slows.

Key entities

  • Jay Schottenstein

    Executive Chairman and CEO of American Eagle Outfitters.

  • Jen Foyle

    President and Executive Creative Director for American Eagle and Aerie.

Related articles

$AEOMed

BMO raises American Eagle Outfitters stock price target on Aerie momentum

BMO Capital raised its price target on American Eagle Outfitters (NYSE:AEO) to $20 from $18, citing strong Aerie brand momentum and improved women's bottoms sales. The stock trades at $17.41 with a P/E ratio of 8.93. BMO expects upside to Q4 gross margin guidance due to lower tariff rates. AEO reported Q2 earnings of $0.79 per share on $1.38 billion revenue, beating estimates. TD Cowen cut its target to $16, while UBS lowered its target to $27 but maintained a Buy rating.

$AEOHighAI 8/10

Earnings Guidance Lift Could Change The Bull Case For American Eagle Outfitters (AEO)?

American Eagle Outfitters (AEO) reported Q2 2026 sales of $1.38B, net income of $134.08M, and EPS of $0.80. The company issued Q3 and full-year 2026 operating income guidance of $110M-$115M and $540M-$550M, respectively. Analysts highlight execution around inventory, markdowns, and digital productivity as key catalysts, while noting risks from consumer caution and cost pressures. The company declared a quarterly dividend of $0.125 per share.

$AEOMedAI 8/10

American Eagle Goes on Sale: Is It Time to Buy?

American Eagle reported Q2 revenue of $1.4B, up 8%, beating expectations. Aerie and OFFLINE segments drove growth, while the core brand faced challenges. Margins were impacted by tariff refunds and markdowns. Analysts trimmed price targets, but the consensus suggests 35% upside. Institutional investors own 98% of the float, showing bullish signs. The core brand's turnaround is a key risk.

$AAPLMed

Apple, Compass Pathways, Aritzia and more analyst calls of the week

Dell shares rose 11% to a record high after RBC initiated coverage with an Outperform rating and $640 target, citing strong AI and PC demand. Apple shares gained 3.1% after unveiling its first foldable iPhone, the iPhone Duo, priced at $1,999 and above. AstraZeneca's shares remained flat despite mixed analyst views on its drug tozorakimab. Compass Pathways shares climbed 4% on positive Phase III study data for its psilocybin treatment.